Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 14/20 | 0.39 |
| ▸ | PPARD | Q03181 | 4/20 | 0.37 |
| ▸ | PPARG | P37231 | 3/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25845812 | 0.91 | CD274 (0.40) | CD274FFAR1PPARDPPARGMAOA | |
| SCHEMBL25846484 | 0.91 | FFAR1 (0.40) | CD274FFAR1PPARDPPARGMAOA | |
| SCHEMBL25845849 | 0.84 | CD274 (0.36) | CD274FFAR1PPARDPPARG | |
| SCHEMBL25845317 | 0.81 | FFAR1 (0.49) | FFAR1PPARDPPARG | |
| SCHEMBL25845503 | 0.81 | FFAR1 (0.49) | FFAR1PPARDPPARG | |
| SCHEMBL25845631 | 0.81 | FFAR1 (0.38) | CD274FFAR1PPARDPPARGMAOA | |
| SCHEMBL25846477 | 0.80 | CD274 (0.40) | CD274FFAR1PPARDPPARG | |
| SCHEMBL25845928 | 0.78 | FFAR1 (0.61) | FFAR1PPARDPPARG | |
| SCHEMBL25844251 | 0.78 | FFAR1 (0.61) | FFAR1PPARDPPARG | |
| SCHEMBL25846331 | 0.78 | FFAR1 (0.40) | CD274FFAR1PPARDPPARGMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230339919-A1 | BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF | AB Pharma Ltd. (CN) | 2023-10-26 | — | — | US | disclosed |
| US-20230339919-A1 | BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF | AB Pharma Ltd. (CN) | 2023-10-26 | — | — | US | disclosed |
| EP-4212528-A1 | BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUND AND MEDICAL APPLICATION THEREOF | AB Pharma Ltd. (CN) | 2023-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339919-A1 | BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF | GPR55, GPR65, GPR4 | CD274 3189/4885FFAR1 52/4885PPARD 141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.